CPT® Code 86255

The CPT® Code 86255 refers to the screening for antibodies to noninfectious agents using a fluorescent technique. This procedure is primarily utilized to detect the presence of specific antibodies in a patient's blood sample or cerebral spinal fluid (CSF). The screening is typically the first step in the diagnostic process, allowing healthcare providers to identify potential autoimmune disorders or other conditions that are not caused by infectious agents. If the screening indicates the presence of antibodies, a subsequent titer count may be performed using CPT® Code 86256 to quantify the level of these antibodies. The antibodies detected through this screening can be associated with various medical conditions, including celiac disease, premature ovarian failure, myasthenia gravis, and other autoimmune disorders. Additionally, this test can help assess exposure to environmental toxins that may lead to autoimmune diseases, as well as monitor conditions such as cancers, graft versus host disease following organ transplants, and myocardial infarction or other cardiac injuries. Furthermore, these antibody screenings and titers can serve as valuable markers for evaluating the effectiveness of immunosuppressant therapy in patients undergoing treatment for autoimmune conditions.